ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

CARLOS CASAS M.D.

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

32,277Medicare Part D Prescriptions Filled, Including Refills

Rank: 19 out of 2888

$2.25M Total Retail Price of All Prescriptions

Rank: 17 out of 2888

842 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

17% of this provider’s 842 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

4% of this provider’s 26,951 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

34% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
OMEPRAZOLE 1,232 1,019 1 7
SIMVASTATIN 983 857 2 2
LEVOTHYROXINE SODIUM 952 849 3 1
JANUVIA 893 718 10 4 48
AMLODIPINE BESYLATE 867 747 5 5
NEXIUM 732 583 6 19
METOPROLOL SUCCINATE 732 649 6 11
CRESTOR 674 572 8 20
HYDROCODONE-ACETAMINOPHEN 585 380 S3 9 4
GABAPENTIN 573 443 10 13
CYMBALTA 563 415 11 44
ATORVASTATIN CALCIUM 547 465 12 9
MELOXICAM 547 447 12 31
FUROSEMIDE 524 472 14 6
JANUMET 509 351 15 131
DONEPEZIL HCL 473 467 16 26
ALENDRONATE SODIUM 472 437 17 23
DIOVAN 462 373 18 35
TRAMADOL HCL-ACETAMINOPHEN 442 408 19 95
SERTRALINE HCL 400 360 20 27
GLYBURIDE-METFORMIN HCL 390 346 R 21 64
GLIMEPIRIDE 375 306 22 36
NAPROXEN SODIUM 362 321 10 23 339
DIGOXIN 361 333 24 55
ENALAPRIL MALEATE 355 335 25 49
ZOLPIDEM TARTRATE 351 250 26 17
METOPROLOL TARTRATE 320 281 27 10
LABETALOL HCL 309 257 28 180
BENAZEPRIL HCL 300 269 29 77
CLOPIDOGREL 286 243 30 30
CARVEDILOL 283 262 31 21
LANTUS 281 194 32 45
DIOVAN HCT 277 243 33 61
METFORMIN HCL 273 213 34 8
EXFORGE 259 248 35 159
POTASSIUM CHLORIDE 250 244 36 14
TAMSULOSIN HCL 245 226 37 29
VOLTAREN 242 205 38 157
AMLODIPINE BESYLATE-BENAZEPRIL 234 218 39 67
CLONIDINE HCL 231 172 40 39
PAROXETINE HCL 230 146 41 84
LOSARTAN POTASSIUM 212 149 42 18
PLAVIX 210 172 43 40
GLIPIZIDE 206 151 44 50
QUETIAPINE FUMARATE 204 175 45 66
EVISTA 201 199 46 125
LOSARTAN-HYDROCHLOROTHIAZIDE 200 194 47 46
IBUPROFEN 198 165 48 87
LANTUS SOLOSTAR 193 146 49 92
GLYBURIDE 188 188 R 50 58
ACTOS 186 153 51 108
LACTULOSE 184 154 52 111
CLOTRIMAZOLE 178 127 53 294
CILOSTAZOL 177 139 54 165
AZITHROMYCIN 176 144 55 38
NABUMETONE 175 125 56 204
TRAMADOL HCL 173 151 57 16
PRAVASTATIN SODIUM 170 138 58 12
POLYETHYLENE GLYCOL 3350 165 141 59 93
CELEBREX 162 139 60 89
LIPITOR 159 128 61 78
NITROGLYCERIN PATCH 154 148 62 183
METFORMIN HCL ER 153 139 63 53
LEVOFLOXACIN 153 121 63 57
HYDROXYZINE HCL 151 103 R 65 174
BUMETANIDE 150 134 66 203
CLOTRIMAZOLE-BETAMETHASONE 147 130 67 136
FLUOXETINE HCL 146 132 68 83
SINGULAIR 143 132 69 85
METOCLOPRAMIDE HCL 143 114 69 116
METHOCARBAMOL 139 100 R 71 176
GLIPIZIDE XL 129 113 72 205
LOVAZA 128 99 73 97
KLOR-CON M20 126 126 74 90
LIDODERM 125 123 75 105
ATENOLOL 124 73 76 25
SPIRIVA 124 109 76 79
FINASTERIDE 116 116 78 102
HYDROCHLOROTHIAZIDE 109 87 79 15
LISINOPRIL 108 95 80 3
VYTORIN 105 78 81 155
DICLOFENAC SODIUM 104 81 82 141
WARFARIN SODIUM 99 78 83 22
MEGESTROL ACETATE 97 86 R 84 140
LYRICA 97 64 84 69
PANTOPRAZOLE SODIUM 95 79 86 33
EXFORGE HCT 94 94 87 303
TRIAMCINOLONE ACETONIDE 94 79 87 145
LEVETIRACETAM 90 70 89 103
SYMBICORT 88 71 90 142
NAMENDA 87 87 91 34
MONTELUKAST SODIUM 87 82 91 153
CEFUROXIME 85 75 93 130
VERAPAMIL ER 84 74 94 104
SPIRONOLACTONE 82 63 95 70
METOLAZONE 79 75 96 215
MECLIZINE HCL 78 76 97 122
PREDNISONE 75 48 98 42
AMITRIPTYLINE HCL 74 74 R 99 74
ESCITALOPRAM OXALATE 72 65 100 62
LISINOPRIL-HYDROCHLOROTHIAZIDE 72 72 100 28
FAMOTIDINE 72 52 100 75
AGGRENOX 71 66 103 223
SEROQUEL 69 61 104 143
PIOGLITAZONE HCL 68 51 R 105 248
CIPROFLOXACIN HCL 68 61 105 47
INSULIN SYRINGE 68 48 105 86
RANITIDINE HCL 67 62 108 56
PEN NEEDLE 66 47 109 110
CARBIDOPA-LEVODOPA 63 63 110 113
PROPRANOLOL HCL 63 40 110 164
DIVALPROEX SODIUM 63 50 110 100
CLINDAMYCIN HCL 62 47 113 253
RAMIPRIL 61 58 114 73
ACTONEL 60 49 115 149
PRAMIPEXOLE DIHYDROCHLORIDE 56 27 116 202
VALSARTAN-HYDROCHLOROTHIAZIDE 55 50 117 368
NORTRIPTYLINE HCL 54 49 118 263
AMIODARONE HCL 53 48 119 167
MIDODRINE HCL 53 22 119 370
SANTYL 52 42 121 210
ISOSORBIDE MONONITRATE ER 52 52 121 51
LEVEMIR 51 48 123 135
FLUTICASONE PROPIONATE 50 47 124 32
DIPHENOXYLATE-ATROPINE 50 24 124 387
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 1, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.